Projects funded by the NCN
Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing the effectiveness of anticancer therapies
2024/53/B/NZ7/04162
Keywords:
Organometallic Compounds Tubulin Polymerization Inhibitors Anticancer Therapies Multitargeted Drug Design Synthesis and Bioactivity Evaluation,
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_15:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 3 389 160 PLN
Project start date (Y-m-d): 2025-02-13
Project end date (Y-m-d): 2029-02-12
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.